Under The Radar
Eyeing an entry on this one. I think current prices are fair to start building a position. Gene editing using Cas9 is still relatively new but has made big strives in such a short time (compared to other therapeutics). Very promising / proven tech but public opinion remains skeptical. Still a barrier for mass adoption. Hard to predict where it goes but am personally bullish on the future of gene therapy.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Saywallahcuzzy : I've been holding since $41. several up and down but the patient is paying off
also recently a few analysts have reaffirmed a buy
Kaibotski Saywallahcuzzy : I'm sitting up here at 67.
103046862 Kaibotski : im stranded at 95